BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park Y, Choi D, Kim SH, Kim SH, Kim MJ, Lee J, Lim JH, Lee WJ, Lim HK. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging. European Journal of Radiology 2006;59:424-31. [DOI: 10.1016/j.ejrad.2006.06.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Hong HS, Byun JH, Won HJ, Kim KW, Lee SS, Lee MG, Yun SC. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement. Clin Radiol 2010;65:701-7. [PMID: 20696297 DOI: 10.1016/j.crad.2010.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Sun J, Dowling JA, Pichler P, Parker J, Martin J, Stanwell P, Arm J, Menk F, Greer PB. Investigation on the performance of dedicated radiotherapy positioning devices for MR scanning for prostate planning. J Appl Clin Med Phys 2015;16:4848. [PMID: 26103166 DOI: 10.1120/jacmp.v16i2.4848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
3 Grazioli L, Bondioni MP, Romanini L, Frittoli B, Gambarini S, Donato F, Santoro L, Colagrande S. Superparamagnetic iron oxide-enhanced liver MRI with SHU 555 A (RESOVIST®): New protocol infusion to improve arterial phase evaluation-A prospective study. J Magn Reson Imaging 2009;29:607-16. [DOI: 10.1002/jmri.21644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]